Scientists make engineered bacteria convert plastic waste into Parkinson’s drug
SMRTR summary
University of Edinburgh researchers successfully engineered E. coli bacteria to convert common plastic waste into L-DOPA, the primary medication for treating Parkinson's disease. This breakthrough transforms polyethylene terephthalate plastic into terephthalic acid, which the bacteria then process into the life-saving drug, creating a sustainable alternative to fossil fuel-based pharmaceutical manufacturing while addressing plastic pollution.
SMRTR provides this summary for quick context. The original article belongs to Interesting Engineering.
Read the original article